Jeffrey Lennox MD
Academic Appointment
- Associate Dean for Clinical Research, Emory University School of Medicine
- Professor of Medicine, Department of Medicine Division of Infectious Diseases, Emory University School of Medicine
Education
Degrees
- MD from University of Colorado School of Medicine
- BA from University of Colorado
Research
Focus
- I am testing new pharmaceutical and immunologic therapies for acute and chronic HIV infection. In addition, my research unit tests strategies for the management of complications of HIV infection or of antiretroviral therapy. Much of this research is done in conjunction with the NIH-funded AIDS Clinical Trials Group, for which I am the Principal Investigator of the Emory HIV/AIDS Clinical Trials Unit. I am also working with younger faculty as a mentor to investigate the predictors of success of antiretroviral therapy,
Publications
-
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned.
Ann Intern Med Volume: 177 Page(s): 1547 - 1557
11/01/2024 Authors: Gulick RM; Pau AK; Daar E; Evans L; Gandhi RT; Tebas P; Ridzon R; Masur H; Lane HC; NIH COVID-19 Treatment Guidelines Panel -
Lymphocyte Count Derived Polygenic Score and Interindividual Variability in CD4 T-cell Recovery in Response to Antiretroviral Therapy.
Pac Symp Biocomput Volume: 29 Page(s): 594 - 610
01/01/2024 Authors: Cardone KM; Dudek S; Keat K; Bradford Y; Cindi Z; Daar ES; Gulick R; Riddler SA; Lennox JL; Sinxadi P -
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Nat Med Volume: 29 Page(s): 2334 - 2346
09/01/2023 Authors: Branche AR; Rouphael NG; Diemert DJ; Falsey AR; Losada C; Baden LR; Frey SE; Whitaker JA; Little SJ; Anderson EJ -
Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy.
J Infect Dis Volume: 228 Page(s): 64 - 69
06/28/2023 Authors: Hastie E; Moser C; Sun X; Lennox J; Hsue PY; Bosch RJ; Deeks S; Meneses MV; Lederman MM; Hunt P -
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
Lancet Respir Med Volume: 10 Page(s): 237 - 246
03/01/2022 Authors: Temesgen Z; Burger CD; Baker J; Polk C; Libertin CR; Kelley CF; Marconi VC; Orenstein R; Catterson VM; Aronstein WS -
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus.
Clin Infect Dis Volume: 74 Page(s): 95 - 104
01/07/2022 Authors: Marconi VC; Moser C; Gavegnano C; Deeks SG; Lederman MM; Overton ET; Tsibris A; Hunt PW; Kantor A; Sekaly R-P -
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study.
J Clin Pharmacol Volume: 61 Page(s): 1555 - 1566
12/01/2021 Authors: Hurwitz SJ; Tao S; Gavegnano C; Jiang Y; Tressler RL; Tsibris A; Del Rio C; Overton ET; Lederman MM; Kantor A -
Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19.
Ann Intern Med Volume: 174 Page(s): 1151 - 1158
08/01/2021 Authors: Kuriakose S; Singh K; Pau AK; Daar E; Gandhi R; Tebas P; Evans L; Gulick RM; Lane HC; Masur H -
Methylprednisolone for Coronavirus Disease 2019 (COVID-19): Was Benjamin Rush Prescient?
Clin Infect Dis Volume: 72 Page(s): e382 - e383
05/04/2021 Authors: Lennox JL -
Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults.
PLoS Genet Volume: 17 Page(s): e1009464
04/01/2021 Authors: Li B; Veturi Y; Verma A; Bradford Y; Daar ES; Gulick RM; Riddler SA; Robbins GK; Lennox JL; Haas DW